Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China

Xuewen Tang, Yanhui Xiao, Xuan Deng, Yang Zhou, Haiping Chen, Rui Yan, Yao Zhu, Shengyi Wang, Hui Wang, Xiujuan Zhu, Linyun Luo, Yan Liu, Zhiying Yin, Guoping Zhang, Zhongbing Chen, Jian Jiang, Xiaoming Yang, Hanqing HeThe Lancet Regional Health - Western Pacific 2023 · DOI

Abstract

Medical and Health Science and Technology of Zhejiang Province (2021KY118). This trial was registered with ClinicalTrials.gov (NCT04576910).
BibTeX
@inproceedings{tang2023immuno,
  author = {Xuewen Tang and Yanhui Xiao and Xuan Deng and Yang Zhou and Haiping Chen and Rui Yan and Yao Zhu and Shengyi Wang and Hui Wang and Xiujuan Zhu and Linyun Luo and Yan Liu and Zhiying Yin and Guoping Zhang and Zhongbing Chen and Jian Jiang and Xiaoming Yang and Hanqing He},
  title = {{Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China}},
  booktitle = {The Lancet Regional Health - Western Pacific},
  year = {2023},
  doi = {10.1016/j.lanwpc.2023.100725},
}

Loading related content...

Figure